Saudi Vision 2030 Programmes
Aligned with the Health Sector Strategy, the Localisation Programme, and the National Industrial Development & Logistics Programme (NIDLP).
Partners & Recognition
Gene Matrix collaborates with hospitals, laboratories, regulators and Vision 2030 programmes to localise diagnostics manufacturing and improve access to validated PCR testing.
Aligned with the Health Sector Strategy, the Localisation Programme, and the National Industrial Development & Logistics Programme (NIDLP).
Engaging with leading hospitals, reference laboratories and screening programmes across the Kingdom for evaluation, validation and clinical adoption.
Building distribution and clinical-partnership relationships across the GCC and the wider MENA region.
Gene Matrix is engaged with national health-localisation initiatives and industrial-development programmes — details available on request.
Partnership Tiers
From distribution and hospital adoption to tech-transfer and research collaboration — we tailor each engagement to the partner.
Exclusive and country-specific arrangements across the GCC and MENA — with quote routing, validated kit shipments and joint clinical-engagement support.
ApplyDirect engagement with hospital systems and screening programmes — validation support, training, and locally manufactured kit supply.
ApplySelective tech-transfer arrangements where in-region manufacturing supports national health priorities and regulatory pathways.
ApplyCollaboration on validation studies, comparative performance and clinical evidence generation with academic and research partners.
ApplyRecognition
Featured engagement on the regional opportunity for diagnostics localisation across the GCC.
Aligned with the Health Sector Strategy and the National Industrial Development & Logistics Programme (NIDLP).
We're actively engaging with distributors, reference laboratories and clinical partners across the GCC and MENA. Tell us where you operate, what you need, and we'll route your enquiry to the right team.
Partner With Us